GNPX - Genprex, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.38 0.09 (22.76%)	0.0 (-0.49%)	0.0 (0.73%)	-0.06 (-11.26%)	0.09 (22.76%)	---	-0.01 (-2.59%)	0.1 (27.29%)

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.17
Diluted EPS:
Basic P/E:: -2.7441
Diluted P/E:
RSI(14) 1m:: 24.98
VWAP:: 0.47
RVol:: 13.9143

Events

Period	Kind	Movement	Occurred At
Day	Rvol 10 increase day	rvol 10.17, 0.54 +0.16 (+43.32%)	Oct 15 07:50
1m	Price increase 1m	0.54 +0.05 (+10.04%)	Oct 15 07:49
1m	Price decrease 1m	0.49 -0.02 (-3.16%)	Oct 15 07:48
1m	Price increase 1m	0.52 +0.01 (+1.46%)	Oct 15 07:46
1m	Price decrease 1m	0.51 -0.01 (-2.61%)	Oct 15 07:45